Zimou Michael W.

HighLight Capital (HLC) is a private investment firm dedicated to creating long-term values through promoting technology innovations. Empowered by our deep knowledge in chemical, biological and material sciences, and leveraging our proprietary industry research and comprehensive enablement services, we strive to invest in companies that boost manufacturing efficiency and improve human wellness. HLC currently manages over US$3.8 billion, with operations across in key financial hubs, such as Tokyo, Shanghai, Hong Kong and Boston.

HighLight Capital (HLC) is a private investment firm dedicated to creating long-term values through promoting technology innovations. Empowered by our deep knowledge in chemical, biological and material sciences, and leveraging our proprietary industry research and comprehensive enablement services, we strive to invest in companies that boost manufacturing efficiency and improve human wellness. HLC currently manages over US$3.8 billion, with operations across in key financial hubs, such as Tokyo, Shanghai, Hong Kong and Boston.

IMS Health has now merged with Quintiles. Visit our new website for more information www.iqvia.com

英诺天使基金成立于2013年4月，投资管理团队平均有10年+经验，管理基金规模超过30亿人民币。英诺天使以“投资 创新，成人达己”为使命，专注人工智能/机器人、大消费/新文创、新一代信息技术、大健康、金融科技等领域的天使、Pre-A轮投资，成立后持续获得“中国早期投资机构十强”等殊荣。 英诺天使建立了跨地域的投资与创业服务平台，在北京、上海、粤港澳湾区(广州、深圳、香港、中山)、厦门、美国硅谷等地均有团队，各地的英诺创新空间已成为优秀年轻人聚集的地方。英诺天使已投创业项目达 400+，包括柠檬微趣、推想科技、臻迪科技、智行者、文远知行、未来黑科技、阿丘科技、变格、微动天下、NetStars、积目等。